Loading…

Papillary thyroid carcinomas with and without BRAF  V600E mutations are morphologically distinct

Finkelstein A, Levy G H, Hui P, Prasad A, Virk R, Chhieng D C, Carling T, Roman S A, Sosa J A, Udelsman R, Theoharis C G & Prasad M L 
(2012) Histopathology 60, 1052–1059 Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct Aims:  The BRAF V600E mutatio...

Full description

Saved in:
Bibliographic Details
Published in:Histopathology 2012-06, Vol.60 (7), p.1052-1059
Main Authors: Finkelstein, Alexander, Levy, Gillian H, Hui, Pei, Prasad, Avinash, Virk, Renu, Chhieng, David C, Carling, Tobias, Roman, Sanziana A, Sosa, Julie A, Udelsman, Robert, Theoharis, Constantine G, Prasad, Manju L
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Finkelstein A, Levy G H, Hui P, Prasad A, Virk R, Chhieng D C, Carling T, Roman S A, Sosa J A, Udelsman R, Theoharis C G & Prasad M L 
(2012) Histopathology 60, 1052–1059 Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct Aims:  The BRAF V600E mutation resulting in the production of an abnormal BRAF protein has emerged as the most frequent genetic alteration in papillary thyroid carcinomas (PTCs). This study was aimed at identifying distinctive features in tumours with and without the mutation. Methods and results:  Thirty‐four mutation‐positive and 22 mutation‐negative tumours were identified by single‐strand conformation polymorphism of the amplified BRAF V600E region in the tumour DNA. Mutation‐positive tumours were more common in patients older than 45 years (24/33, P = 0.05), in classic (23/30, P = 0.01), tall cell (4/5) and oncocytic/Warthin‐like (2/2) variants of PTC, and in subcapsular sclerosing microcarcinomas (4/4). In contrast, all 12 follicular variants (P 
ISSN:0309-0167
1365-2559
DOI:10.1111/j.1365-2559.2011.04149.x